Zivo Bioscience (ZIVO)

$10.25 0.00 (N/A)
Market Cap 40.77M
Revenue (ttm) 160,000.00
Net Income (ttm) -13.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -8,362.50%
Debt to Equity Ratio 0.00
Volume 400
Avg Vol 1,326
Day's Range N/A - N/A
Shares Out 3.98M
Stochastic %K 53%
Beta 0.19
Analysts Hold
Price Target $12.00

Company Profile

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pe...

Industry: Biotechnology
Sector: Healthcare
Phone: 248 452 9866
Address:
2125 Butterfield Drive, Suite 100, Troy, United States
nick275
nick275 Sep. 15 at 1:45 AM
$ZIVO — I took a closer look at the new U.S. patent issued this month. The patent covers poultry feed containing LPS derived specifically from Variovorax paradoxus or Rhodobacter sphaeroides at roughly 0.5–5 lb/ton. These appear to be the same organisms/materials ZIVO has actually been developing in its poultry program. The claim is fairly narrow. Potential design-arounds could include another bacterial LPS source, different concentrations, drinking-water administration instead of feed, or a different immune-modulating molecule. ZIVO originally pursued much broader claims, but the patent ultimately issued with only 3 claims and is subject to a terminal disclaimer, suggesting meaningful overlap with ZIVO’s earlier IP. ZIVO had already disclosed these same two bacterial species, poultry feed and overlapping dosage concepts in an earlier patent family
0 · Reply
AmigoMike
AmigoMike Sep. 14 at 7:44 PM
$ZIVO Looks like the link in prior post may not work for everyone . Here is the basic link and you can just type "zivo" in the basic search section to get the list of patents. Total of 5 issued so far this year. https://ppubs.uspto.gov/basic/
0 · Reply
AmigoMike
AmigoMike Sep. 14 at 5:27 PM
$ZIVO new patent issued to ZIVO September 1, 2026 for methods of immune priming to accelerate immune response. Specifically calls out coccidiosis Time for news https://ppubs.uspto.gov/api/pdf/downloadPdf/US-12721889-B2?source=USPAT&requestToken=eyJzdWIiOiIyYTZhOTJmMi1iZGVhLTQ2ZDktYTU3Yy04YzkyOGQwNTk4YjEiLCJ2ZXIiOiJmMzA1NTMxMC0xNTZiLTRjYjMtOTI1Yi1hNDBlZTM2NGNhOGEiLCJleHAiOjB9
0 · Reply
trprofit
trprofit Sep. 9 at 4:58 PM
$ZIVO AI's "Take" on the matter: OH, LET IT BE SO!! The Mystery Partnership: In mid-2025 and updated in May 2026, ZIVO Bioscience announced a collaboration with a "leading global animal health company" to evaluate and advance its immune-modulating biological compounds to combat coccidiosis in poultry. Because Merck Animal Health is one of the world's largest providers of poultry vaccines and therapeutics, industry observers frequently speculate that Merck is the undisclosed partner conducting the dosing trials. Coccidiosis Focus: ZIVO’s product is a non-antibiotic treatment designed to protect birds from gut diseases. Major animal health corporations like Merck are actively looking for alternative treatments to antibiotics due to changing regulations and consumer demand, fueling the rumors of a potential future acquisition or out-licensing deal.
2 · Reply
AmigoMike
AmigoMike Sep. 8 at 3:38 PM
$ZIVO Summer is over and definitely past time for the action to begin. As noted the other day, I think some information on coccidiosis testing is due and whether we are moving to negotiation stage to bring this thing to commercial stage. We know it works. The test was about the economics. Cosmetics is from the OTC presentation. Although thats not fully clear who and what there. Something is on the burner. Same with dummies. Gummies as far as I know is the fastest growing delivery method for supplements. So if thats what it takes to sell more ZivoLife, then bring it. It doesnt take that long. Hence the need IMO for ZIVO to bring in other distributors for the algae. There's no question it's better tha spirulina but ZWorldwide has had more than enough time to gain market traction.
0 · Reply
nick275
nick275 Sep. 7 at 9:42 PM
$ZIVO hopefully the hurricane doesn’t hit $CYAN . I wouldn’t expect an update from Zivo regardless. What happened to the algae ponds in Peru?
0 · Reply
trprofit
trprofit Sep. 4 at 5:37 PM
$ZIVO September is finally here! Let's get this last Summer holiday weekend out of the way and get back to business, eh?
0 · Reply
S2h7o
S2h7o Aug. 31 at 9:45 AM
$ZIVO I am expecting some type of announcement in Q4. I think the two key things of the announcement will be: 1. Success of the minimal level study 2. What is the partner wanting to do; nothing, further study, extend exclusive relationship, enter into commercial negotiations/relationship. The second point will be the key.
2 · Reply
AmigoMike
AmigoMike Aug. 26 at 4:05 PM
$ZIVO Welp. Looking like another month of nothingness from ZIVO and partner ZWorldwide. Based in the June presentation, I am looking for news coming next month related to dosage testing from animal pharma partner and those result. At this point it is more than 2 dozen tests on coccidiosis. We know the stuff works. Also based on June presentation, sounded like a cosmetics application deal should also be coming in September. As to ZWorldwide, who the hell knows. Gummies maybe. Zivolike is producing zero revenue to the company. So something gotta give there. I am certain CYAN is up and ready to supply whatever quantities are needed. SO LETS GET SOMETHING DONE !
0 · Reply
nick275
nick275 Aug. 21 at 4:51 PM
$ZIVO there is no ability with current leadership to execute. Sadly I do not see this changing since the largest shareholders control the company and have for over 15 years of decline. The product does seem to work, but they need someone with business sense to start executing deals and generating revenue and profits.
0 · Reply
Latest News on ZIVO
No data available.
nick275
nick275 Sep. 15 at 1:45 AM
$ZIVO — I took a closer look at the new U.S. patent issued this month. The patent covers poultry feed containing LPS derived specifically from Variovorax paradoxus or Rhodobacter sphaeroides at roughly 0.5–5 lb/ton. These appear to be the same organisms/materials ZIVO has actually been developing in its poultry program. The claim is fairly narrow. Potential design-arounds could include another bacterial LPS source, different concentrations, drinking-water administration instead of feed, or a different immune-modulating molecule. ZIVO originally pursued much broader claims, but the patent ultimately issued with only 3 claims and is subject to a terminal disclaimer, suggesting meaningful overlap with ZIVO’s earlier IP. ZIVO had already disclosed these same two bacterial species, poultry feed and overlapping dosage concepts in an earlier patent family
0 · Reply
AmigoMike
AmigoMike Sep. 14 at 7:44 PM
$ZIVO Looks like the link in prior post may not work for everyone . Here is the basic link and you can just type "zivo" in the basic search section to get the list of patents. Total of 5 issued so far this year. https://ppubs.uspto.gov/basic/
0 · Reply
AmigoMike
AmigoMike Sep. 14 at 5:27 PM
$ZIVO new patent issued to ZIVO September 1, 2026 for methods of immune priming to accelerate immune response. Specifically calls out coccidiosis Time for news https://ppubs.uspto.gov/api/pdf/downloadPdf/US-12721889-B2?source=USPAT&requestToken=eyJzdWIiOiIyYTZhOTJmMi1iZGVhLTQ2ZDktYTU3Yy04YzkyOGQwNTk4YjEiLCJ2ZXIiOiJmMzA1NTMxMC0xNTZiLTRjYjMtOTI1Yi1hNDBlZTM2NGNhOGEiLCJleHAiOjB9
0 · Reply
trprofit
trprofit Sep. 9 at 4:58 PM
$ZIVO AI's "Take" on the matter: OH, LET IT BE SO!! The Mystery Partnership: In mid-2025 and updated in May 2026, ZIVO Bioscience announced a collaboration with a "leading global animal health company" to evaluate and advance its immune-modulating biological compounds to combat coccidiosis in poultry. Because Merck Animal Health is one of the world's largest providers of poultry vaccines and therapeutics, industry observers frequently speculate that Merck is the undisclosed partner conducting the dosing trials. Coccidiosis Focus: ZIVO’s product is a non-antibiotic treatment designed to protect birds from gut diseases. Major animal health corporations like Merck are actively looking for alternative treatments to antibiotics due to changing regulations and consumer demand, fueling the rumors of a potential future acquisition or out-licensing deal.
2 · Reply
AmigoMike
AmigoMike Sep. 8 at 3:38 PM
$ZIVO Summer is over and definitely past time for the action to begin. As noted the other day, I think some information on coccidiosis testing is due and whether we are moving to negotiation stage to bring this thing to commercial stage. We know it works. The test was about the economics. Cosmetics is from the OTC presentation. Although thats not fully clear who and what there. Something is on the burner. Same with dummies. Gummies as far as I know is the fastest growing delivery method for supplements. So if thats what it takes to sell more ZivoLife, then bring it. It doesnt take that long. Hence the need IMO for ZIVO to bring in other distributors for the algae. There's no question it's better tha spirulina but ZWorldwide has had more than enough time to gain market traction.
0 · Reply
nick275
nick275 Sep. 7 at 9:42 PM
$ZIVO hopefully the hurricane doesn’t hit $CYAN . I wouldn’t expect an update from Zivo regardless. What happened to the algae ponds in Peru?
0 · Reply
trprofit
trprofit Sep. 4 at 5:37 PM
$ZIVO September is finally here! Let's get this last Summer holiday weekend out of the way and get back to business, eh?
0 · Reply
S2h7o
S2h7o Aug. 31 at 9:45 AM
$ZIVO I am expecting some type of announcement in Q4. I think the two key things of the announcement will be: 1. Success of the minimal level study 2. What is the partner wanting to do; nothing, further study, extend exclusive relationship, enter into commercial negotiations/relationship. The second point will be the key.
2 · Reply
AmigoMike
AmigoMike Aug. 26 at 4:05 PM
$ZIVO Welp. Looking like another month of nothingness from ZIVO and partner ZWorldwide. Based in the June presentation, I am looking for news coming next month related to dosage testing from animal pharma partner and those result. At this point it is more than 2 dozen tests on coccidiosis. We know the stuff works. Also based on June presentation, sounded like a cosmetics application deal should also be coming in September. As to ZWorldwide, who the hell knows. Gummies maybe. Zivolike is producing zero revenue to the company. So something gotta give there. I am certain CYAN is up and ready to supply whatever quantities are needed. SO LETS GET SOMETHING DONE !
0 · Reply
nick275
nick275 Aug. 21 at 4:51 PM
$ZIVO there is no ability with current leadership to execute. Sadly I do not see this changing since the largest shareholders control the company and have for over 15 years of decline. The product does seem to work, but they need someone with business sense to start executing deals and generating revenue and profits.
0 · Reply
trprofit
trprofit Aug. 11 at 8:10 PM
$ZIVO Every day is one step closer to Sept! Pull it off Yaldo!! In the mean time, buy a Powerball ticket, and if you win, share it with the board!
1 · Reply
nick275
nick275 Aug. 3 at 10:25 PM
$ZIVO Strome is a big holder in $BEAT.X and this stock appears on its way to zero. If he was to liquidate his position in Zivo to cover any losses in $BEAT , it’s going to get ugly.
1 · Reply
AmigoMike
AmigoMike Jul. 2 at 4:37 PM
$ZIVO So which one of you has been bidding this stock for some size since the virtual conference ?
0 · Reply
AmigoMike
AmigoMike Jun. 26 at 12:19 PM
$ZIVO Looks like the presentation is on You Tube now https://www.youtube.com/channel/UCg4aDJl8JSdTrly_xTHGJhA Apparently multiple irons in the fire to expand the algae business either via standalone or ingredient verticals. POCing gummies as a delivery format. Multiple NDAs here. Lotta compare to spirulina. ZIVO algae better on all the key measures. Potential for replacement of spirulina in formulations. University of Georgia didn't get alot of play and no specifics but testing the algae as a component of their gov't grant award for avian flu is in the testing protocols phase apparently. Partner for coccidiosis doing dosing study after which there's a 90 day window to exclusively formalize license (assuming all goes well). Cyanotech came up a couple times. Yaldoo didn't specifically know the grow cycle but I'm 99% sure it's basically 2 weeks under normal conditions. A little more to start from scratch. Made in the USA, cheap shipping, plenty of expansion capacity, no tariffs. I thought Q&A part was better
0 · Reply
trprofit
trprofit Jun. 25 at 2:21 PM
$ZIVO Virtual Investor Conference 06242026 https://events.virtualinvestorconferences.com/eventRegistration/console/apollox/mainEvent?&eventid=5405808&sessionid=1&username=&partnerref=&format=fhvideo1&mobile=&flashsupportedmobiledevice=&helpcenter=&key=DD6B0FCE93A8F9A50CBB32CE4DD36697&source=GATEWAY-4814904|LP&rId=4814904&rKey=02858952A385CC3B94AD7A1D6C212D6C&oriontokens=eventId-5405808|userId-834016418|gatewayId-4814904|experienceId-|contentType-webcast|hideDownloadPDF-false&newConsole=true&nxChe=true&newTabCon=true&consoleEarEventConsole=true&consoleEarCloudApi=false&text_language_id=en&playerwidth=748&playerheight=526&eventuserid=834016418&contenttype=A&mediametricsessionid=718649153&mediametricid=7557808&usercd=834016418&mode=launch
1 · Reply
nick275
nick275 Jun. 23 at 2:42 PM
$ZIVO Listen to the investor conference presentation to see if Zivo is making progress or if they stumble over talking points.
0 · Reply
trprofit
trprofit Jun. 22 at 3:57 PM
$ZIVO Bring it home ZIVO! Last Project Update was May 28, 2026 News of some deal soon??
0 · Reply
nick275
nick275 Jun. 5 at 10:59 PM
$ZIVO disappointed Zivo has not signed a revenue generating deal with a food processor. They are leaving a tremendous amount of money on the table and continue to fail to execute. Bewildering why Yaldoo, Strome, and Maggiore do not push harder for this company to execute.
0 · Reply
zampy
zampy Jun. 4 at 8:35 PM
$ZIVO 2 shares on big news.... warrants are WORTHLESS....Nov/Dec heavy tax losses.....No one will pay $$$ for this...18 years of failures..... Epic Failure
1 · Reply
AmigoMike
AmigoMike May. 29 at 3:40 PM
$ZIVO @trprofit I see you beat me to posting this update over here. Good news in that many thought coccidiosis was dead. Obviously not with a major animal pharma further agreeing to take on a commercial scale test. Fits within the compliance guidelines as we all know these tests have to get to commercial size. I figure results are early August timeframe on this. I'm still of the opinion a pharma deal for coccidiosis makes this a $50 stock. Validation and doors open to more verticals. No real market reaction cause 99.9% of the public and of ZIVO investors haven't seen this update. Of course I anticipate this update will be met with a "yawn" .... i.e. another test. Dunno if this is a new pharma or prior pharma taking the next step .... but commercial scale test .... with intent to find minimum dosage ... determines the economics of commercial viability. Of course we all know this stuff works. Just a matter of money at this point.
0 · Reply
trprofit
trprofit May. 29 at 1:59 PM
$ZIVO They didn't wait until Friday this time. https://www.zivobioscience.com/news-media/project-updates/detail/1581/project-update-may-2026
1 · Reply
nick275
nick275 May. 18 at 7:31 PM
$ZIVO I reviewed the Q1 filing. Expenses significantly cut. Once revenue is generated it will flow right to net profit. Remeber, Zivo has a massive carryover loss to apply against future profits. This is going to pop once a deal is signed. Leadership of this company finally understands Zivo is not a never ending science experiment and needs to be run like a business.
1 · Reply